Concerns about efficacy and safety of statins in the prevention of stroke.

, High-dose atorvastatin after stroke or transient ischemic attack. The New England Journal of Medicine. ,vol. 355, pp. 549- 559 ,(2006) , 10.1056/NEJMOA061894

Jane Armitage, The safety of statins in clinical practice The Lancet. ,vol. 370, pp. 1781- 1790 ,(2007) , 10.1016/S0140-6736(07)60716-8

Beatrice A Golomb, John J McGraw, Marcella A Evans, Joel E Dimsdale, Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance. Drug Safety. ,vol. 30, pp. 669- 675 ,(2007) , 10.2165/00002018-200730080-00003

Helmut Sinzinger, Roswitha Wolfram, Bernhard A. Peskar, Muscular side effects of statins. Journal of Cardiovascular Pharmacology. ,vol. 40, pp. 163- 171 ,(2002) , 10.1097/00005344-200208000-00001

Luca Mascitelli, Francesca Pezzetta, Statins for primary prevention of coronary artery disease. The Lancet. ,vol. 369, pp. 1078- 1079 ,(2007) , 10.1016/S0140-6736(07)60518-2

Chong Do Lee, Aaron R. Folsom, Steven N. Blair, Physical Activity and Stroke Risk A Meta-Analysis Stroke. ,vol. 34, pp. 2475- 2481 ,(2003) , 10.1161/01.STR.0000091843.02517.9D

Maurizio Paciaroni, Michael Hennerici, Giancarlo Agnelli, Julien Bogousslavsky, Statins and stroke prevention. Cerebrovascular Diseases. ,vol. 24, pp. 170- 182 ,(2007) , 10.1159/000104474

Tom Skyhøj Olsen, Rune Haubo Bojesen Christensen, Lars Peter Kammersgaard, Klaus Kaae Andersen, Higher Total Serum Cholesterol Levels Are Associated With Less Severe Strokes and Lower All-Cause Mortality. Ten-Year Follow-Up of Ischemic Strokes in the Copenhagen Stroke Study Stroke. ,vol. 38, pp. 2646- 2651 ,(2007) , 10.1161/STROKEAHA.107.490292

Paul D Thompson, David Buchner, Ileana L Piña, Gary J Balady, Mark A Williams, Bess H Marcus, Kathy Berra, Steven N Blair, Fernando Costa, Barry Franklin, Gerald F Fletcher, Neil F Gordon, Russell R Pate, Beatriz L Rodriguez, Antronette K Yancey, Nanette K Wenger, None, Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease A Statement From the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity) Circulation. ,vol. 107, pp. 3109- 3116 ,(2003) , 10.1161/01.CIR.0000075572.40158.77

OY Bang, JL Saver, DS Liebeskind, S Starkman, P Villablanca, N Salamon, B Buck, L Ali, L Restrepo, F Vinuela, G Duckwiler, R Jahan, T Razinia, B Ovbiagele, None, Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis Neurology. ,vol. 68, pp. 737- 742 ,(2007) , 10.1212/01.WNL.0000252799.64165.D5